| 摘要 |
The invention concerns polymorphisms in a UCP2 molecule or fragment thereof. The invention further concerns polymorphisms in a nucleic acid molecule encoding UCP2 or fragment thereof. The invention also pertains to agents and methods for detecting such polymorphisms. The invention further pertains to the use of such agents and methods in the diagnosis, prognosis, and treatment selection for obesity, non-insulin-dependent diabetes mellitus, and other UCP2-related diseases. |
